The Turku Site, with 550 employees, represents one of PerkinElmer’s major manufacturing and product development sites for newborn-, maternal fetal health-, and prenatal screening. As the global market leader in newborn screening, our solutions have tested over 560 million babies worldwide for life-threatening diseases.
What we offer:
For more information please contact Petri Kallio, Operations Director at firstname.lastname@example.org or by phone at 040 7096 076 on May 21st between 10 – 11 or on May 24th between 13 – 15.
This position provides an exciting opportunity to work in a highly international business environment. If you are interested in the position and feel that you have the necessary skills and experience, please fill your application by May 27th 2018.
The PerkinElmer Turku Site is a drug free site and a medical examination for new employees includes a drug test.